GlassScriptPhysician profile
Kyle J Kirchner
NPI 1598110868
$13,942.42
in general payments reported to CMS, 2019-2025
23 companies · $2,236 in 2025
The $2,236 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,243 · 2020: $290 · 2021: $1,851 · 2022: $1,828 · 2023: $2,709 · 2024: $1,785 · 2025: $2,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,777 · Travel and Lodging: $2,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,776.76 |
| Travel and Lodging | $2,952.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $3,185.67 | 2021-2023 | |
| Stryker Corporation | $1,310.59 | 2021-2025 | Augment Injectable, Easyfuse, Inbone |
| Paragon 28, INC. | $1,180.44 | 2019-2025 | Portfolio, Phantom Fibula Nail, Ankle Fracture |
| Kerecis Limited | $1,172.41 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Arthrex, INC. | $1,062.78 | 2023-2024 | |
| Crossroads Orthopedics, LLC | $1,033.49 | 2019 | |
| Smith+Nephew, INC. | $991.81 | 2019-2023 | Journey II, Grafix, Oasis |
| Histosonics, INC. | $918.97 | 2025 | |
| Organogenesis INC. | $460.97 | 2021-2023 | Puraply |
| Amniox Medical, INC. | $452.96 | 2019 | |
| Treace Medical Concepts, INC. | $418.02 | 2019-2024 | |
| Oak Med, INC. | $391.52 | 2024 | |
| Flower Orthopedics Coporation | $343.22 | 2019-2025 | |
| Biotissue Holdings INC. | $277.95 | 2019 | |
| Acera Surgical, INC. | $190.91 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $178.60 | 2024-2025 | Motoband, N/A, Fibulink |
| Paratek Pharmaceuticals, INC. | $149.15 | 2025 | Nuzyra |
| Integra Lifesciences Corporation | $109.18 | 2020-2021 | |
| Orthofix Medical, INC. | $35.30 | 2020-2021 | |
| Kci USA, INC. | $23.29 | 2021 | |
| Averitas Pharma INC. | $22.81 | 2025 | Qutenza |
| Polynovo North America LLC | $19.33 | 2025 | Novosorb Btm |
| Fusion Orthopedics USA, LLC | $13.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Kirchner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.